Dimensional Fund Advisors LP Crinetics Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 392,196 shares of CRNX stock, worth $21.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
392,196
Previous 546,759 28.27%
Holding current value
$21.5 Million
Previous $24.5 Million 18.2%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$43.83 - $54.98 $6.77 Million - $8.5 Million
-154,563 Reduced 28.27%
392,196 $20 Million
Q2 2024

Aug 09, 2024
SELL
$42.12 - $51.91 $3.96 Million - $4.88 Million
-94,043 Reduced 14.68%
546,759 $24.5 Million
Q1 2024

May 10, 2024
SELL
$34.76 - $46.81 $664,576 - $894,960
-19,119 Reduced 2.9%
640,802 $30 Million
Q4 2023

Feb 07, 2024
SELL
$25.62 - $37.07 $2.18 Million - $3.15 Million
-84,895 Reduced 11.4%
659,921 $23.5 Million
Q3 2023

Nov 09, 2023
BUY
$15.97 - $30.59 $3.6 Million - $6.9 Million
225,707 Added 43.48%
744,816 $22.2 Million
Q2 2023

Aug 09, 2023
BUY
$15.73 - $23.6 $1.09 Million - $1.64 Million
69,504 Added 15.46%
519,109 $9.35 Million
Q1 2023

May 12, 2023
SELL
$15.31 - $21.1 $907,010 - $1.25 Million
-59,243 Reduced 11.64%
449,605 $7.22 Million
Q4 2022

Feb 09, 2023
SELL
$15.49 - $19.05 $421,668 - $518,579
-27,222 Reduced 5.08%
508,848 $9.31 Million
Q3 2022

Nov 10, 2022
SELL
$18.11 - $22.37 $322,376 - $398,208
-17,801 Reduced 3.21%
536,070 $10.5 Million
Q2 2022

Aug 12, 2022
BUY
$16.49 - $27.64 $1.06 Million - $1.78 Million
64,514 Added 13.18%
553,871 $10.3 Million
Q1 2022

May 13, 2022
BUY
$17.15 - $28.31 $2.47 Million - $4.07 Million
143,913 Added 41.66%
489,357 $10.7 Million
Q4 2021

Feb 09, 2022
BUY
$19.35 - $28.41 $659,835 - $968,781
34,100 Added 10.95%
345,444 $9.81 Million
Q3 2021

Nov 12, 2021
BUY
$16.88 - $25.23 $2.13 Million - $3.18 Million
126,051 Added 68.03%
311,344 $6.55 Million
Q2 2021

Aug 12, 2021
BUY
$15.9 - $21.15 $1.9 Million - $2.53 Million
119,573 Added 181.94%
185,293 $3.49 Million
Q1 2021

May 14, 2021
BUY
$13.3 - $17.55 $556,272 - $734,028
41,825 Added 175.04%
65,720 $1 Million
Q4 2020

Feb 25, 2021
BUY
$12.08 - $17.46 $288,651 - $417,206
23,895 New
23,895 $337,000

Others Institutions Holding CRNX

# of Institutions
241
Shares Held
79.6M
Call Options Held
23.3K
Put Options Held
44.3K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.94B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email